This is with reference to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 requiring the Company to intimate every amendment to Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.
Accordingly the Board of Directors of the Company has on March 31 2019 approved the revision to the same effective from April 1 2019 and the same has been made available on the website of the Company.
This is for your information and record.
Kindly acknowledge the receipt.
Panacea Biotec: Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
April 1, 2019